If you have heart disease, talk with your provider to see if you qualify
6.2 Modulation of gut microbiota Recent research suggests that GLP-1 receptor agonists significantly affect the composition of gut microbiota, revealing a new mechanism that contributes to metabolic advantages (Liang et al
Together, we can do more to ensure that GLP-1 treatments evolve from blunt tools for weight loss into precision approaches for optimizing metabolic and neuro-protective outcomes, while safeguarding skeletal muscle mass and preserving gut microbiome health
This makes semaglutide a great choice for those with obesity or being overweight, along with other health problems
GLP-1R agonists effect(s) on vascular smooth muscle cells are equally important to those on endothelial cells with several favorable responses being reported, including enhanced differentiation, attenuated response to reactive oxygen species, reduced vascular remodeling through improved mitochondrial activity and dynamics, and the prevention of aberrant migration [65]